Europe Drug Of Abuse Testing Services Market Size & Outlook
The drug of abuse testing services market in Europe is expected to reach a projected revenue of US$ 1,347.3 million by 2033. A compound annual growth rate of 4.7% is expected of Europe drug of abuse testing services market from 2026 to 2033.
Quest Diagnostics Inc, Abbott Laboratories, Clinical Reference Laboratory, Cordant Health Solutions, ZeOmega, Psychemedics Corp, Millennium HealthCare Inc, Mayo Clinic, Precision Diagnostics, LGC Group, Labcorp Drug Development, Legacy Medical, Drugscan, USDTL
Other key industry trends
In terms of revenue, Europe region accounted for 24.2% of the global drug of abuse testing services market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 1,090.5 million by 2033.
Europe held the second-largest share in the drug of abuse testing services market, in 2019. This can be attributed to the increasing prevalence of drug abuse and substance use disorder in key countries, including Germany, the UK, France, Italy, and Spain.
In addition, growing number of initiatives undertaken by several regulatory bodies to increase drug abuse testing is anticipated to create a high demand for drug of abuse testing services.
However, many European countries have forbidden workplace drug testing or random screening, while several countries allow it in safety-critical industries such as energy, transport, and construction. Thus, such unclear regulations related to workplace drug testing in some countries may limit the demand for drugs of abuse testing serveries and hinder the market.
Europe Drug Of Abuse Testing Services Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Drug Of Abuse Testing Services Market Outlook will help companies and investors design strategic landscapes.
Cannabis/Marijuana was the largest segment with a revenue share of 52.43% in 2025.
Horizon Databook has segmented the Europe drug of abuse testing services market based on cocaine, cannabis/marijuana, others drug type, amphetamine & methamphetamine, lsd, alcohol, opioids covering the revenue growth of each sub-segment from 2021 to 2033.
Europe held the second-largest share in the drug of abuse testing services market, in 2019. This can be attributed to the increasing prevalence of drug abuse and substance use disorder in key countries, including Germany, the UK, France, Italy, and Spain.
In addition, growing number of initiatives undertaken by several regulatory bodies to increase drug abuse testing is anticipated to create a high demand for drug of abuse testing services.
However, many European countries have forbidden workplace drug testing or random screening, while several countries allow it in safety-critical industries such as energy, transport, and construction. Thus, such unclear regulations related to workplace drug testing in some countries may limit the demand for drugs of abuse testing serveries and hinder the market.
Europe Drug Of Abuse Testing Services Market Drug Type Outlook (Revenue, USD Million , 2021-2033)
Cocaine
Cannabis/Marijuana
Others Drug Type
Amphetamine & Methamphetamine
LSD
Alcohol
Opioids
Reasons to subscribe to Drug Of Abuse Testing Services Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Drug Of Abuse Testing Services Market Outlook databook
Our clientele includes a mix of Drug Of Abuse Testing Services Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Drug Of Abuse Testing Services Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Drug Of Abuse Testing Services Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Drug Of Abuse Testing Services Market, 2021-2033 (US$M)